Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$20.76 USD
+0.74 (3.70%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $20.73 -0.03 (-0.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -1.35 |
EPS Last Quarter | -1.46 |
Last EPS Surprise | 0.68% |
ABR | 1.54 |
Earnings ESP
|
-3.02% |
---|---|
Current Year | -5.57 |
Next Year | -5.51 |
EPS (TTM) | -5.41 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.60M | 19.96M | 50.96M | 72.19M |
# of Estimates | 7 | 10 | 13 | 11 |
High Estimate | 34.17M | 37.82M | 102.50M | 210.00M |
Low Estimate | 10.00M | 11.00M | 12.23M | 9.00M |
Year ago Sales | 12.61M | 13.59M | 36.28M | 50.96M |
Year over Year Growth Est. | 23.74% | 46.84% | 40.49% | 41.66% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.35 | -1.31 | -5.57 | -5.51 |
# of Estimates | 12 | 11 | 15 | 12 |
Most Recent Consensus | -1.40 | -1.56 | -6.36 | -6.91 |
High Estimate | -1.02 | -1.03 | -4.55 | -4.03 |
Low Estimate | -1.45 | -1.68 | -6.52 | -7.09 |
Year ago EPS | -1.17 | -1.40 | -5.42 | -5.57 |
Year over Year Growth Est. | -15.38% | 6.43% | -2.77% | 1.09% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.35 | -1.31 | -5.57 | -5.51 |
7 Days Ago | -1.35 | -1.31 | -5.57 | -5.51 |
30 Days Ago | -1.35 | -1.31 | -5.57 | -5.51 |
60 Days Ago | -1.36 | -1.31 | -5.56 | -5.52 |
90 Days Ago | -1.45 | -1.38 | -5.75 | -5.98 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.39 | -1.31 | -5.53 | -5.66 |
Zacks Consensus Estimate | -1.35 | -1.31 | -5.57 | -5.51 |
Earnings ESP | -3.02% | 0.00% | 0.66% | -2.80% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.46 | -1.38 | -1.40 | -1.17 | NA |
Estimate | -1.47 | -1.52 | -1.32 | -1.41 | NA |
Difference | 0.01 | 0.14 | -0.08 | 0.24 | 0.08 |
Surprise | 0.68% | 9.21% | -6.06% | 17.02% | 5.21% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more